Viewing Study NCT05114603

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:14 PM

Ignite Modification Date: 2026-02-05 @ 6:34 AM

Study NCT ID: NCT05114603

Status: UNKNOWN

Last Update Posted: 2022-05-03

First Post: 2021-10-29

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation

Sponsor: Shanghai Henlius Biotech

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module